The company made this announcement after market hours on Wednesday, 26 March 2008.
Meanwhile, the BSE Sensex was down 88.18 points or 0.55% to 15,998.26 after a drop in US durable goods stroked concerns the US is already in a recession.
On BSE, 1.12 lakh shares of the scrip were traded. The stock had an average daily volume of 3.17 lakh shares on BSE in past one quarter.
The scrip touched a high of Rs 41.35 and a low of Rs 37.50 so far during the day. The stock had hit a 52-week high of Rs 101.70 on 2 January 2008 and a 52-week low of Rs 31.80 on 24 March 2008.
The scrip had underperformed the market over the past one month till 26 March 2008, declining 32.40% compared to the Sensex’s fall of 9.66%. It also underperformed the market in the past one quarter, declining 52.69% compared to Sensex’s decline of 20.43%.
The small-cap pharmaceuticals firm has an equity capital of Rs 16.87 crore. Face value per share is Rs 2. Promoters hold 55.47% stake in the company (as at end December 2007).
At the current price of Rs 40.75, the scrip trades at a PE multiple of 8.05, based on Q3 December 2007 annualised EPS of Rs 5.06.
The company’s latest reserves and latest book value per share stand at Rs 404.26 crore and Rs 49.93 respectively.
J B Chemicals & Pharmaceuticals’ net profit declined 45.30% to Rs 10.67 crore on 2.90% rise in net sales to Rs 139.02 crore in Q3 December 2007 over Q3 December 2006.
J B Chemicals & Pharmaceuticals manufactures basic chemicals, petrochemicals, pharmaceuticals, photographic chemicals and agro-based products.
No comments:
Post a Comment